Author: Kerry Clough

The UK Technology Strategy Board

Kerry Clough, Corporate Partnerships Manager (Medicine)
Kerry Clough, Corporate Partnerships Manager (Medicine)

The UK Technology Strategy Board (TSB) is a funding organisation which Imperial has arguably underutilised in recent years, and for any of our scientists seeking collaborations with industry they are an excellent source of potential leverage funding. The TSB launched its 2013-14 Delivery Plan in May. In their role as the UK’s innovation agency they have a budget of £440m over the next year to help accelerate economic growth by stimulating and supporting business-led innovation. They will establish and implement national technology strategies in the priority areas which include energy, transport, health, digital, space, biosciences, IT, high value manufacturing and advanced materials.

TSB awarded over 60% of their R&D investment to small and medium-sized enterprises during the last year and ran more than 70 competitions for R&D funding, offering grants to over 1,000 organisations. In 2013-14 they plan to launch around 75 more competitions across the priority themes, committing almost £300m. They are working with more than 4,900 companies and 150 research organisations, including 110 universities and all of their 7 so-called Catapult centres (world-leading centres of innovation in their field of expertise) will become operational in 2013.

Kerry Clough
Corporate Partnerships Manager
Faculty of Medicine